1. Home
  2. RWT vs ESPR Comparison

RWT vs ESPR Comparison

Compare RWT & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Redwood Trust Inc.

RWT

Redwood Trust Inc.

HOLD

Current Price

$5.26

Market Cap

707.5M

Sector

Real Estate

ML Signal

HOLD

Logo Esperion Therapeutics Inc.

ESPR

Esperion Therapeutics Inc.

HOLD

Current Price

$3.13

Market Cap

731.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RWT
ESPR
Founded
1994
2008
Country
United States
United States
Employees
351
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
707.5M
731.9M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
RWT
ESPR
Price
$5.26
$3.13
Analyst Decision
Buy
Strong Buy
Analyst Count
7
4
Target Price
$6.82
$8.75
AVG Volume (30 Days)
1.2M
16.6M
Earning Date
04-29-2026
05-07-2026
Dividend Yield
12.83%
N/A
EPS Growth
N/A
60.71
EPS
N/A
N/A
Revenue
N/A
$403,135,000.00
Revenue This Year
$26.59
N/A
Revenue Next Year
$22.21
$12.81
P/E Ratio
N/A
N/A
Revenue Growth
N/A
21.31
52 Week Low
$5.00
$0.76
52 Week High
$6.97
$4.18

Technical Indicators

Market Signals
Indicator
RWT
ESPR
Relative Strength Index (RSI) 31.02 70.78
Support Level $5.04 $2.37
Resistance Level $5.39 $3.18
Average True Range (ATR) 0.14 0.07
MACD -0.05 0.11
Stochastic Oscillator 4.00 96.01

Price Performance

Historical Comparison
RWT
ESPR

About RWT Redwood Trust Inc.

Redwood Trust Inc is a specialty finance company focused on several distinct areas of housing credit. The company delivers customized housing credit investments to a diverse mix of investors through securitization platforms, whole-loan distribution activities, and its publicly traded securities. The company has four reportable segments: Sequoia Mortgage Banking, CoreVest Mortgage Banking, Redwood Investments, and Legacy Investments. Maximum revenue is generated from the Sequoia Mortgage Banking segment, comprising a mortgage loan conduit that acquires residential consumer loans from third-party originators for subsequent sale to whole loan buyers, securitization through its SEMT private-label securitization program, or transfer into its Redwood Investments portfolio.

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a commercial-stage biopharmaceutical company currently focused on bringing new medicines to patients that address unmet medical needs. It has developed and is commercializing U.S. Food and Drug Administration, or FDA, approved oral, once-daily, non-statin medicines for patients who are at risk for cardiovascular disease (or CVD and are struggling with elevated low-density lipoprotein cholesterol, or LDL-C. The Company views its operations and manages its business in one operating segment, which is the business of researching, developing, and commercializing therapies for the treatment of patients with elevated LDL-C. The company depends almost entirely on the success of two products, the bempedoic acid tablet and the bempedoic acid/ezetimibe combination tablet.

Share on Social Networks: